Investors Still Face Plenty of Risks in 2026: What to Watch
As 2026 unfolds, a mix of rate shifts, debt pressures, and geopolitical strains create a tricky path for investors. T...
Using index funds with active funds works best in markets with clear diversification needs and where costs and risk management matter most.
21,614 articlesAs 2026 unfolds, a mix of rate shifts, debt pressures, and geopolitical strains create a tricky path for investors. T...
A high-flying biotech spin-off has faced a brutal disconnect between hype and reality. This beaten-down growth stock ...
As Anthropic prepares an IPO, history warns that sky-high private valuations rarely translate into smooth public-mark...
A surprising drop in Sandisk shares has many investors recalibrating their bets on memory chips. This guide explains ...
Rocket Lab shares tumbled as markets reeled from AI stock valuations and macro uncertainty. This guide breaks down th...
Arweave's AR token is in focus as investors map a path for 2025 through 2030. This piece outlines the key drivers, sc...
When a beverage maker expands beyond a single hero brand, the investment narrative changes. Celsius transformed its g...
Navitas Semiconductor is pursuing an AI data-center power strategy built around 800V architecture. This move could re...
Investors just got a fresh catalyst as Uber commits to autonomous progress. This article breaks down what Dara Khosro...
A new Ethereum-based play-to-earn title, Meme Punch, launches its medieval arena with MEPU rewards. The game blends m...
Broadcom's AI outlook miss triggered a pronounced one-day pullback, signaling investor caution around AI-driven growt...
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...